Utilidad del electromiograma en el diagnóstico de las miopatías inflamatorias

Hilton-Jones, 2011, Observations on the classification of the inflammatory myopathies, Presse Med, 40, 199, 10.1016/j.lpm.2010.10.035 Nava, 2009, Abordaje en el diagnóstico diferencial de las miopatías inflamatorias, Reumatol Clin, 5, 32, 10.1016/j.reuma.2009.07.003 López Longo, 2008, Miopatías inflamatorias. Nuevos conceptos, Reumatol Clin, 4, 40, 10.1016/S1699-258X(08)76139-4 Amato, 2009, Evaluation and treatment of inflammatory myopathies, J Neurol Neurosurg Psychiatry, 80, 1060, 10.1136/jnnp.2008.169375 Amato, 2009, Inclusion body myositis: old and new concepts, J Neurol Neurosurg Psychiatry, 80, 1186, 10.1136/jnnp.2009.173823 Bohan, 1977, Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis, Medicine (Baltimore), 56, 255, 10.1097/00005792-197707000-00001 Kyriakides, 2010, EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia, Eur J Neurol, 17, 767, 10.1111/j.1468-1331.2010.03012.x Levin, 1987, The time course of creatine kinase elevation following concentric needle EMG, Muscle Nerve, 10, 242, 10.1002/mus.880100308 Lynch, 2008, Complications of needle electromyography: Hematoma risk and correlation with anticoagulation and antiplatelet therapy, Muscle Nerve, 38, 1225, 10.1002/mus.21111 Boon, 2011, Hematoma risk after needle EMG, Muscle Nerve, 44, 439 Bautista-Lorite, 2008, Miopatías, 355 Rojas-García, 2008, Análisis de la actividad muscular espontánea, 107 Fernández-Rodríguez, 2008, Análisis de la actividad muscular voluntaria, 119 Lacomis, 2002, Electrodiagnostic approach to the patient with suspected myopathy, Neurol Clin N Am, 20, 587, 10.1016/S0733-8619(01)00013-5 Blijham, 2006, Needle Electromyographic Findings in 98 Patients with Myositis, Eur Neurol, 55, 183, 10.1159/000093866 Catoggio, 2009, Tratamiento y pronóstico [de las miopatías inflamatorias], Reumatol Clin, 5, 35, 10.1016/j.reuma.2009.07.004 Fuglsang-Frederiksen, 2006, The role of different EMG methods in evaluating myopathy, Clin Neurophysiol, 117, 1173, 10.1016/j.clinph.2005.12.018 Mastaglia, 2008, When the treatment does not work: polymyositis, Pract Neurol, 8, 170 Benveniste, 2011, Myositis or dystrophy? Traps and pitfalls, Presse Med, 40, 249, 10.1016/j.lpm.2010.11.023 Gutiérrez-Gutiérrez, 2010, Miopatías producidas por tóxicos industriales, animales y vegetales, Rev neurol, 51, 360 Ayllón-Muñoz, 2002, Miopatía inducida por colquicina con miotonía asociada, Rev Neurol, 35, 195 Kuncl, 2003, Exocytotic constipation is a mechanism of tubulin/lysosomal interaction in colchicine myopathy, Exp Cell Res, 285, 196, 10.1016/S0014-4827(03)00034-X Rutkove, 1998, Myotonia in colchicine myoneuropathy, Muscle Nerve, 21, 550, 10.1002/(SICI)1097-4598(199804)21:4<551::AID-MUS20>3.0.CO;2-Z Casado, 2006, Antimalarial myopathy: an underdiagnosed complication?., Prospective longitudinal study of 119 patients, Ann Rheum Dis, 65, 385, 10.1136/ard.2004.023200 Abdel-Hamid, 2008, Severe hydroxycholoquine myopathy, Muscle Nerve, 38, 1206, 10.1002/mus.21091 Siddiqui, 2007, Hydroxycloroquine-induced toxic myopathy causing respiratory failure, Chest, 131, 585, 10.1378/chest.06-1146 2005, 575